Nexentis Share Price
NASDAQ: NXTS | Micro Cap | Healthcare$1.85
+$1.85 (--%) Last updated on 18 Nov, 2026 | 20:31 ISTNexentis Stock Performance
Nexentis Share Price Chart
$1.85$1.85
L
H
Nexentis Quarterly Profit & Loss
All figures in USD
Corporate Actions
About Nexentis
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
Nexentis Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.55 | $1.85 | +213.56% |
Oct 2026 | $1.41 | $0.59 | -60.00% |
Sep 2026 | $1.73 | $1.48 | -23.97% |
Aug 2026 | $1.79 | $1.94 | +10.86% |
Jul 2026 | $4.25 | $1.75 | -59.40% |
Jun 2026 | $5.38 | $4.31 | -31.91% |
May 2026 | $4.46 | $6.33 | +27.62% |
Apr 2026 | $0.64 | $4.96 | +660.74% |
Mar 2026 | $0.90 | $0.65 | -35.45% |
Feb 2026 | $1.00 | $1.01 | N/A |